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To be effective against the oxidative damages induced by UVB irradiation in the skin, the drug needs to 
release from the formulation in which it was incorporated and reach the skin layers where the ROS are 
generated. Thus, it is very important the development of a robust and sensitive methodology to extract 
and quantify in different skin layers the antioxidant agent delivered from topical formulations. Therefore, 
in the present work suitable methods to extract and quantify quercetin in skin samples and receptor phase 
after in vitro penetration studies were developed. The results demonstrated that the recovery from two 
different layers of skin, the SC and [E+D], using two different methods of quantification (DPPH· assay 
and HPLC, respectively), was 93.8 % when the quercetin spiked dose was 50 µg/mL, 100.4 % when it 
was 100 µg/mL and 89.9 % for 250 µg/mL and the average recovery of the quercetin extraction from 
receptor phase when dichloromethane was used as extractor solvent was 96%. These results demonstrate 
that the described methods have a potential application to in vitro skin penetration studies of quercetin, 
since it showed to be accurate and sensitive.
Uniterms: Topical formulations/analysis. Quercetin/quantification. Quercetin/extraction. Quercetin/
liberation. Skin penetration in vitro/study. High performance liquid chromatography. DPPH·.
Para ser efetiva contra os danos oxidativos induzidos pela radiação UVB na pele, é necessário que o ativo 
seja liberado da formulação na qual foi incorporado e alcance as camadas da pele onde são geradas as 
EROS. Desta forma, torna-se de grande importância o desenvolvimento de métodos eficazes e sensíveis 
para extrair e quantificar, nas diferentes camadas de pele, o agente antioxidante liberado de formulações 
tópicas. No presente trabalho foram desenvolvidos métodos adequados para extrair e quantificar a 
quercetina em amostras de pele e na fase receptora após estudos de penetração cutânea in vitro. Os 
resultados demonstraram que a recuperação das camadas de pele, EC e [E+D], quando do uso de duas 
diferentes metodologias de quantificação (ensaio de DPPH· e CLAE, respectivamente), foi de 93,8 % 
quando aplicada uma dose de 50 µg/mL de quercetina, 100,4 % para 100 µg/mL e 89,9 % para 250 µg/mL 
e a recuperação média da extração da quercetina da fase receptora, quando do emprego de diclorometano 
como solvente extrator, foi de 96 %. Tais resultados demonstram que os métodos descritos têm grande 
potencial de aplicação em estudos de penetração in vitro já que apresentaram exatidão e sensibilidade.
Unitermos: Formulações tópicas/análise. Quercetina/quantificação. Quercetina/extração. Quercetina/
liberação. Penetração cutânea in vitro/estudo. Cromatografia líquida de alta eficiência. DPPH·.
INTRODUCTION
Skin is the largest human organ, and is the only organ 
directly exposed to ultraviolet (UV) irradiation. Chronic 
exposure to UV irradiation causes premature skin aging, 
local and systemic immunosuppression, decrease in the 
skin antioxidant defence and ultimately photocarcinoge-
nesis (Boudjelal et al., 2000; Xu, Fisher, 2005). Reactive 
oxygen species (ROS) are implicated in UV-light induced 
damage to skin and could be an initiator in the pathoge-
nesis of skin cancer and photoaging (Podda et al., 1998).
Therefore, considering that few tissues in the body 
are subjected to similar degrees of oxidative stress expo-
sure, it has been suggested the beneficial effect of topical 
antioxidant, which might be a successful strategy for di-
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minishing UV radiation-mediated oxidative damage of the 
skin. In this context, recently work has demonstrated the 
beneficial effectiveness of topical formulations containing 
quercetin, a flavonoid which has well-known antioxidant 
activity, in inhibiting the oxidative stress and inflammation 
induced by UVB irradiation (Casagrande et al., 2006a).
Nevertheless, the primary requirement for topical 
therapy is that a drug incorporated into a vehicle reach 
the skin surface and penetrates at an adequate rate and 
in sufficient amount (Röpke et al., 2002). Then, the 
evaluation of topical absorption of quercetin becomes a 
crucial step in studies suggesting the possible use of this 
flavonoid in topical formulations. This evaluation also re-
quires the development of a robust and sensitive method 
to extract and quantify this drug in the skin, in order to 
predict if adequate amounts of drug were delivered from 
the formulation and reach viable layers of skin, where 
the ROS are generated.
Casagrande et al. (2007) proposed the use of the 
measurement of antioxidant activity as an efficient appro-
ach to evaluate quercetin skin retention. Nevertheless, the 
recovery obtained when this methodology is employed 
was not evaluated. 
Therefore, one of the objectives of the present study 
was the development of simple and accurate methods to 
extract quercetin from stratum corneum (SC) and epi-
dermis (E) plus dermis (D) ([E+D]) of porcine ear skin, 
quantifying the drug in homogenates of these skin layers 
using the previous validated methods: DPPH· and HPLC, 
respectively. 
Considering that different studies have demonstrated 
the poor quercetin ability to permeate through excised 
human and porcine skin and that it has been proposed the 
topical use of this flavonoid to control UVB-induced oxi-
dative skin damages (Casagrande et al., 2007; Saija et al., 
1998), it is important to develop a sensitive methodology 
to extract and determine very small amounts of this drug 
which might permeate through skin and also to assure, 
when a topical formulation is used, that all the drug applied 
was retained in the skin. Therefore, this work aimed also 
to develop a simple, reproducible and sensitive method 
to extract and quantify quercetin from receptor medium. 
MATERIAL AND METHODS
Chemicals and reagents
Quercetin dihydrate 99% (C
15
H10O7.2H2O, Mw = 
338.26) was purchased from Acros Organics (New Jer-
sey, USA), propylene glycol and polyoxyethylene (20) 
sorbitan monolaurate (Tween® 20) from Synth (Diadema, 
SP, Brazil), and 2,2-diphenyl-1-picryl-hydrazyl (DPPH·) 
from Sigma Chemical Co. (St. Louis, MO, USA). All 
used organic solvents were HPLC grades and provided 
by J.T.Baker (USA) and Merck (Darmstadt, Germany). 
All other chemicals were of reagent grade and were used 
without further purification. 
Skin preparations
Briefly, the skin from the outer surface of a freshly 
excised porcine ear was carefully dissected and dermato-
mized, stored at -20 °C, and used within a month.
Quercetin recovery from porcine skin
The absolute recovery of quercetin from skin tissue 
was determined adding 200 mL of methanolic quercetin 
solutions (50, 100 and 250 mg/mL) in skin sections (area 
of 1.77 cm2). These spiked skin sections (n=3 for each 
concentration) were allowed to rest for 20 minutes. Quer-
cetin was assessed in two different skin layers: SC and 
[E+D]. To separate the SC from the remaining [E+D], 
skin sections were subjected to tape stripping. The tape 
stripping technique is being increasingly used to measure 
drug concentration and its concentration profile across 
the stratum corneum (Moser et al. 2001). This skin layer 
was stripped with 15 pieces of adhesive tape, which were 
immersed in 4 mL methanol, vortex stirred for 1 min, bath 
sonicated for 15 min and the methanolic phase filtered 
using 0.45 mm membrane. The evaporated filtrate resi-
due was suspended in 500 mL of methanol and quercetin 
was assayed by measuring its antioxidant activity by the 
DPPH● assay, as described below. 
The remaining [E + D] were cut in small pieces, 
vortex mixed for 2 min in 4 mL of methanol, and bath so-
nicated for 30 min. The resulting mixture was then filtered 
using a 0.45 mm membrane, and quercetin was assayed in 
the filtrate by HPLC method as described below. The ab-
solute recovery of quercetin extracted from skin layers was 
determined considering the sum of quercetin quantities in 
both skin layers (SC + [E + D]).
The same experiments were also done by adding 
200 mL of quercetin solutions in methanol (50, 100 and 
250 mg/mL) in skin sections having its SC previously remo-
ved by the tape stripping procedure, in order to determine 
the recovery percentage only of quercetin extracted from 
[E + D]. 
Quercetin recovery from receptor phase
In order to identify a suitable receptor medium for in 
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vitro experiments, the saturation solubility of quercetin in 
different media was analyzed. Three media were tested: (i) 
0.15 M phosphate buffer (pH 7.2), (ii) 0.15 M phosphate 
buffer (pH 7.2) plus 10% of ethanol and (iii) 0.15 M phos-
phate buffer (pH 7.2) plus 0.5% of polyoxyethylene (20) 
sorbitan monolaurate (Tween® 20). An excess of quercetin 
was added to the media at 37 °C and stirred for 12 h. After 
filtering (Millex LCR filter 0.45 mm), the quercetin content 
was analyzed by HPLC method (Casagrande et al., 2007; 
Saija et al., 1998).
To determine the recovery of quercetin from 
receptor phase this drug was extracted from selected 
receptor medium (0.15 M phosphate buffer, pH 7.2 plus 
0.5% of Tween® 20) by liquid-liquid extraction method 
using the organic solvents hexane, dichloromethane and 
chloroform. 
For this analysis it was prepared quercetin solutions 
in 0.15 M phosphate buffer, pH 7.2 plus 0.5% of Tween® 
20 in the concentrations of 0.05, 0.1, 0.5, 1.0, 2.0 and 
5.0 mg/mL. Five hundred microlitres of each solution were 
withdrawn and quercetin was extracted from each sample 
using 3 mL of extractor solvent. After the organic phase 
was evaporated, the residue was suspended in 100 mL of a 
methanol: water (60:40 v/v) mixture containing 2% acetic 
acid, and quercetin was assayed by HPLC as described 
below. 
After the selection of the best solvent extractor, it 
was evaluated the recovery of quercetin after the extraction 
process. The recovery (R) was determined using the for-
mula below and the obtained concentration determined by 
using the regression equation of quercetin analytical curve: 
Recovery (R) = (obtained concentration / real concentra-
tion) x 100
Since the recovery obtained was not satisfactory, the 
pH of 0.15 M phosphate buffer, pH 7.2 plus 0.5% of Twe-
en® 20 solution containing quercetin was altered to 4.0, 
5.0 and 8.6 and after being selected the most appropriate 
one, all the extraction proceedings and recovery analysis 
were done again.
In order to evaluate the effectiveness of the solvent 
drying procedure, it was prepared methanolic quercetin so-
lutions at the same concentrations, in the range of 0.05-5.0 
mg/mL, and the extraction stage was omitted. For this, ap-
propriate volumes of methanolic quercetin solutions were 
evaporated and the residue was suspended in 100 mL of a 
methanol: water (60:40 v/v) mixture containing 2% acetic 
acid, being quercetin then assayed by HPLC method. The 
quercetin recovery after the solvent drying procedure was 
evaluated as described above. 
In vitro skin penetration and percutaneous 
delivery
The methodology developed for quercetin quanti-
fication in porcine skin was used to determine quercetin 
skin penetration after in vitro cutaneous penetration and 
percutaneous delivery experiments. On the day of the 
experiment, the skin was thawed and mounted on a Franz 
diffusion cell (diffusion area of 1.77 cm2; Hanson Instru-
ments, Chatsworth, CA), with the SC facing the donor 
compartment (where the formulation was applied) and 
the dermis facing the receptor compartment. The latter 
compartment was filled with 150 mM phosphate buffer 
(pH 7.2) containing Tween® 20 (0.5%). The receptor phase 
was under constant stirring and maintained at 37 ± 0.5 °C. 
One hundred milligrams of a solution composed of 
quercetin at 0.3% (w/w) in propylene glycol (n=5) and 
a w/o microemulsion containing quercetin in the same 
final percentage (n=5) were applied to the surface of the 
stratum corneum.
At 12 h post-application, skin surfaces were tho-
roughly washed with distilled water and wiped with a 
cotton swab to remove excess formulation. Quercetin 
was extracted from SC, [E + D] and from receptor phase 
using the methodologies described above. The amounts 
of quercetin detected in SC and in [E + D] are indicative 
of its penetration in the skin, whereas the amount in the 
receptor phase is indicative of its percutaneous delivery.
Analytical methodology for quercetin
HPLC method
HPLC analyses were used to determine quercetin 
concentration in the [E+D] and receptor phase (trans-
dermal delivery) and to identify a suitable receptor me-
dium for quercetin. The HPLC apparatus consisted of a 
Shimadzu (Kyoto, Japan) liquid chromatograph system, 
equipped with an LC-10 AT VP solvent pump unit and an 
SPD-10A VP UV-Visible detector. Samples were injected 
manually through a 20 mL loop with a Rheodyne injector. 
The separation was performed in a C18 Hypersyl BDS-
CPS ciano (5 mm), 250 x 4.6 mm column with a mobile 
phase of methanol: water (60:40 v/v) containing 2% acetic 
acid (flow rate of 1 mL/min) and quercetin detected at 
254 nm. Data were collected using a Chromatopac CR8A 
integrator (Shimadzu, Kyoto, Japan). 
Antioxidant activity by the DPPH · assay 
Stratum corneum quercetin was measured by its 
antioxidant activity in the DPPH· assay due to HPLC lack 
of selectivity.
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The quercetin H-donor ability was evaluated using 
an ethanol solution of DPPH·, a stable nitrogen-centered 
free radical. Briefly, for radical scavenging measurements, 
1 mL of 0.1 M acetate buffer (pH 5.5), 1 mL of ethanol and 
0.5 mL of 250 mM ethanolic solution of DPPH· were mixed 
with 50 mL of the test sample and the light absorbance 
measured after 10 min at 517 nm (Blois, 1958; Dinis et 
al., 1994). Positive control was prepared using control skin 
sections (untreated), which indicated the maximum odd 
DPPH· electrons, considered as 100% free radicals in the 
solution and used to calculate the hydrogen-donating abil-
ity of quercetin (%). To determine SC extracted quercetin, 
the % H-donating ability was transformed in quercetin 
concentrations (mg/mL) using the regression equation 
obtained by plotting concentrations of quercetin against 
hydrogen-donating ability (%) for each concentration. 
The blank was prepared from the reaction mixture without 
DPPH● solution and all measurements were performed in 
triplicate. 
RESULTS AND DISCUSSION
The beneficial effect of the use of topical antioxi-
dants, such as the flavonoid quercetin, in order to reduce 
UV radiation-mediated oxidative damage of the skin has 
been suggested (Casagrande et al., 2006a; Saija et al., 
1998). Nevertheless, suitable percutaneous absorption is 
known to be an essential requirement for satisfactory topi-
cally applied photoprotective agents (Bonina et al., 1996; 
Saija et al., 1998). Although Casagrande et al. (2007) had 
suggested an efficient approach to evaluate the quercetin 
skin retention released from topical formulations, the 
recovery of the proposed methodology was not evaluated 
and to date, no study was aimed to develop a robust and 
sensitive method to extract and quantify quercetin from 
different skin layers.
The HPLC method has been widely used to sepa-
rate and quantify flavonoids presents in plants and foods 
(Careri et al., 2000; Saija et al., 1998). Previous work of 
our group demonstrated the precision and accuracy of the 
chromatographic method developed for the quantitative 
determination of quercetin. Values obtained with standard 
methanolic quercetin solutions showed linearity over the 
concentration range of 0.1 to 200 mg/mL with a correlation 
coefficient (r) of 0.999. The quantification limit in the 
HPLC assay was 0.03 mg/mL and the average for relative 
standard variation and error was no more than 4.68% in 
all concentrations tested, which is considered adequate for 
analytical assay (Vicentini et al., 2007b). 
Firstly, the selectivity of this HPLC-UV method was 
verified by evaluating the interference of compounds from 
skin and from the adhesive tape on the assay of quercetin. 
Figure 1 shows chromatogram of [E+D] homogenates 
from control skin sections and demonstrates that the 
compounds of skin did not interfere with the analysis of 
quercetin. Nevertheless, the adhesive tape used for the tape 
stripping procedure caused interference, some compound 
present in the adhesive tape showed similar retention 
time to that obtained for quercetin, when analyzed under 
the same chromatographic conditions. Then, the HPLC 
method proposed was selective only for the evaluation of 
the quercetin present in the [E+D]. Therefore, the DPPH· 
assay was used as an alternative approach to evaluate the 
possible retained quercetin in the SC.
DPPH· is a stable free radical that can accept an 
electron or hydrogen radical converting into stable, dia-
magnetic molecule. Because of its odd electron, DPPH· 
has a strong absorption band at 517 nm. As this electron 
becomes paired off, the absorption decreases stoichiome-
trically with respect to the number of electrons taken up. 
Such a change in absorbance produced in this reaction has 
been widely used to test the ability of several molecules to 
act as free radical scavengers (Dinis et al., 1994).
FIGURE 1 – Chromatogram of [E+D] homogenates compared 
to the profile of a 5 mg/mL quercetin solution. Chromatographic 
conditions: C18 Hypersyl BDS-CPS ciano (5 mm), 250 x 
4.6 mm column - attached to a pre column, mobile phase: 
methanol: water (60:40 v/v) containing 2% acetic acid, 1 mL/
min. Detection at 254 nm.
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Quercetin antioxidant activity has been demonstrated 
by different in vitro methods such as lipid peroxidation in-
duced by Fe2+/citrate (Casagrande et al., 2006b; Vicentini 





system (Georgetti et al., 2003; Vicentini et al., 2007a) and 
DPPH· assay (Pinelo et al., 2004; Silva et al., 2002; Tsi-
mogiannis, Oreopoulou, 2004; Vicentini et al., 2007a). The 
last one was chosen to be used in the analysis of quercetin 
retained in SC because besides to be an easy, inexpensive, 
fast and precise methodology to measure the antioxidant 
activity (Nuutila et al. 2003), the validation of this method, 
using methanolic solutions of quercetin showed its sensi-
tivity, adequacy and reproducibility to measure the antio-
xidant activity of this flavonoid (Vicentini et al., 2007b). 
Furthermore, in the present work it was evaluated the skin 
components and adhesive tape interference in the detection 
of quercetin antioxidant activity using this methodology and 
the results showed that DPPH· assay is a selective method 
to analyze the quercetin present in the SC (data not shown). 
Therefore, the DPPH· assay was used to determine the 
amount of quercetin in SC and HPLC was used to quantify 
the amount of this flavonoid in [E+D]. 
The recovery percentage of quercetin extracted 
from skin layers (SC + [E + D]) and only [E + D] was 
showed in Table I. By comparing the results obtained by 
Lopes and Bentley (2005) in terms of cyclosporine reco-
very from skin layers, the use of the same methodologies 
was more efficient in the recovery of quercetin. Thus, the-
se high recoveries obtained for different concentrations 
demonstrate that the methods for quercetin extraction 
and quantification in different skin layers, described in 
the present study, were very suitable to be employed on 
cutaneous penetration studies. Furthermore, the determi-
nation of the retained quercetin in the SC by measuring 
its antioxidant activity showed to be an important and 
reliable alternative.
Casagrande et al. (2007) and Saija et al. (1998) de-
monstrated that quercetin did not permeate when different 
vehicles containing this flavonoid were topically applied. 
Nevertheless, it has been suggested that using a different 
approach it might be possible to detect quercetin in the 
receptor medium (Casagrande et al., 2007). Therefore, the 
development of a reliable method to extract and quantify 
the quercetin present in the receptor medium is very impor-
tant to determine the possible permeation of this flavonoid 
and also to assure, if a topical formulation is applied, that 
no quercetin permeates through the skin.
First of all, the optimal receptor medium was selec-
ted. The selection of the receptor solution is an important 
decision to create in vitro conditions, which can adequately 
replicate the in vivo conditions. The receptor solution has an 
important influence on the in vitro absorption of compounds 
with low aqueous solubility such as quercetin. Solubilizers 
are commonly used to increase the solubility of drugs in 
the receptor solution, to assure sink conditions without 
apparent damage to skin. As a general rule, the concentra-
tion of the permeant should not be allowed to exceed 10% 
of saturation solubility (Casagrande et al., 2007; Moser et 
al., 2001). Therefore, in the present study, phosphate buffer 
(pH 7.2; 0.15 M) containing Tween® 20 (0.5%), in which 
quercetin has a solubility of 27.93 ± 0.26 mg/mL (Table II) 
was selected to be used as receptor phase. 
Since it is well known the poor ability of quercetin 
to permeate the skin, the development of a robust and sen-
sitive method to extract and quantify this flavonoid from 
the receptor medium is essential in the analysis of topical 










(mean ± SD) (µg/cm2)
Recovery (%) 
([E+ D])
5.65 5.30±0.53 93.8 5.08±0.98 90.0
11.30 11.35±0.72 100.4 9.83±0.76 87.0
28.25 25.42±0.70 89.9 24.01±0.86 84.9
TABLE II - Saturation solubility of quercetin in different media
Medium Solubility (µg/mL)
0.15 M phosphate buffer (pH 7.2) 0.48±0.072
0.15 M phosphate buffer (pH 7.2) + 10% ethanol 2.40±0.021
0.15 M phosphate buffer (pH 7.2) + 0.5% Tween®20 27.93±0.26
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and transdermal delivery of quercetin from different types 
of vehicles (Bonina et al., 1996; Casagrande et al., 2007).
Therefore, to concentrate and analyze this flavonoid 
by HPLC, quercetin was extracted from receptor medium 
(0.15 M phosphate buffer, pH 7.2 plus 0.5% of Tween® 
20) by liquid-liquid extraction method. This is a simple 
method in which a variety of organic solvents can be used 
and, for this reason, it gives a wide rate of selectivity and 
solubility (Queiroz et al., 2001).
Three different solvents, which have different pola-
rities, were tested in order to select the one that has the best 
extractor power for quercetin in the employed conditions. 
The organic solvent chloroform showed a peak in the same 
retention time of quercetin, which might be due to impurities 
of this solvent that were concentrated with the flavonoid 
during the samples drying process. The second solvent 
employed was hexane, but this one was not able to extract 
quercetin from aqueous solution because of its smaller 
polarity. Dichloromethane, which has intermediate polarity 
when compared to hexane and chloroform, was the solvent 
that best extracts quercetin from the receptor medium. The 
average of recovery for all the different concentrations of 
quercetin employed was 80%. Nevertheless, to improve 
these results the pH of aqueous solution was changed in 
order to obtain the quercetin in non-ionized form, which 
will increase its partition to organic portion. Since this 
flavonoid is insoluble in water, it is difficult to assess its 
pKa then it was necessary to evaluate the recovery when 
applied different pHs (4.0, 5.0 and 8.6). The first one was 
the most reproducible and showed an average recovery of 
96% as shown in Table III. Furthermore, the evaluation 
of the efficiency of the extractor solvent drying procedure 
showed total recovery of the active quercetin (Table IV).
Then, the results demonstrated that the method deve-
loped to extract quercetin from receptor medium, changing 
the final pH of this to 4.0 and using dichloromethane as 
solvent extractor, was sensitive and reproducible since it 
showed a high recovery of the flavonoid. 
At 12 h post-application of a propylene glycol so-
lution and a w/o microemulsion formulation containing 
quercetin in the final concentration of 0.3% (w/w), 9.40 
± 0.57 µg/cm2 (n=5) of quercetin was detected in the SC 
and 0.13 ± 0.03 µg/cm2 in the [E+D] for the first one and 
16.94 ± 0.84 µg/cm2 (n=5) in the SC and 2.51 ± 0.12 µg/
cm2 in the [E+D] for the microemulsion (Figure 2). No 
quercetin was detected in the receptor medium. These 
results demonstrated that the methods developed in the 
present work were suitable to determine the penetration 
in different skin layers and percutaneous delivery of quer-
cetin when this was topically applied.
TABLE III - Recovery of the extraction procedure of quercetin from receptor medium (final pH = 4) using dichloromethane as 
extractor solvent
Real concentration (µg/mL) Obtained concentration (mean ± SD) 
(µg/mL)
Recovery (%)
0.05 0.056 ± 0.009 112.0
0.10 0.08 ± 0.01 80.0
0.50 0.48 ± 0.06 96.0
1.0 1.03 ± 0.18 103.2
2.0 1.97 ± 0.12 98.5
5.0 4.55 ± 0.88 91.0
TABLE IV - Recovery of quercetin after the drying procedure of the extractor solvent
Real concentration (µg/mL) Obtained concentration (mean ± SD) 
(µg/mL)
Recovery (%)
0.05 0.059 ± 0.10 118.0
0.10 0.09 ± 0.05 90.0
0.50 0.51 ± 0.09 102.0
1.0 1.00 ± 0.25 100.0
2.0 2.05 ± 0.13 102.5
5.0 4.90 ± 0.90 98.0
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CONCLUSION
The combined procedures of extraction and DPPH · 
assay of quercetin in the SC and HPLC assay of quercetin 
in [E+D] and in receptor phase are efficient in terms of 
drug recovery and rapid manipulation. Furthermore, consi-
dering the therapeutic advantages of topical administration 
of quercetin to control UVB-induced oxidative damages, 
the proposed methodologies for quercetin assay in samples 
of different skin layers and in receptor medium, from in 
vitro and even in vivo studies, could be very important in 
the design and evaluation of topical and transdermal drug 
delivery.
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